Cross-Cultural Adaptation and Reliability Testing of Chinese Version of the Living with Medicines Questionnaire in Elderly Patients with Chronic Diseases

Overview

Journal Patient Prefer Adherence

Date 2020 Dec 28

PMID 33363363

Citations 7

Authors

Yongli Wang

Janet Krska

Beilei Lin

Yongxia Mei

Barbra Katusiime

Yawen Guo

Zhenxiang Zhang

Affiliations

Soon will be listed here.

Abstract

Background: The Living with Medicines Questionnaire (LMQ-3) is a reliable, valid instrument used to assess the medication-related burden of patients with chronic disease using long-term medication, but it has not been used in China.

Purpose: To translate and cross-culturally adapt the LMQ-3 into Chinese and assess its reliability and validity among elderly patients with chronic disease.

Methods: After translation and back-translation, views from an expert group and cognitive interviews with elderly persons using multiple medicines were used to ensure the cultural relevance of the LMQ-3. Then, 412 participants aged 60-92 years were recruited from three communities in Zhengzhou to complete the instrument. Item analysis, internal consistency, content validity, exploratory factor analysis (EFA) and reliability testing were performed.

Results: Item analysis identified nine items for possible removal, which were discussed with the originating team. Internal consistency testing confirmed the suitability of removing two of these items, which concurred with the views of the expert group and cognitive interviews. All other items were retained, but four were modified for clarification without changing their meaning, resulting in a 39-item instrument. EFA of this 39-item measure yielded an eight-factor model, similar to the English version. Cronbach's alpha of the Chinese version of LMQ-3 (C-LMQ-3) for elderly patients with chronic diseases was 0.855, and alpha values for the eight domains ranged from 0.822 to 0.932. Test-retest reliability was satisfactory, with ICC values for the eight domain scores ranging from 0.751 to 0.881.

Conclusion: With only minor modifications compared to the English version, the 39-item C-LMQ-3 is a valid tool, with adequate reliability, which can be used to assess the medication-related burden of long-term use of multiple medicines in elderly patients in China.

Citing Articles

Prevalence and influencing factors of medication-related burden among patients with late-life depression in typical city of eastern China: a cross-sectional study.

Liu D, Qiu L, Han L, Wang Y, Wang F, Liu X BMC Public Health. 2024; 24(1):3521.

PMID: 39696225 PMC: 11658140. DOI: 10.1186/s12889-024-20939-2.

Choice intention for the national volume-based procurement drug and its associated factors: a cross-sectional study on patients with late-life depression in China.

Wu J, Qiu L, Li J, Zhou Q, Xie W, Shen Y BMC Psychiatry. 2024; 24(1):580.

PMID: 39192190 PMC: 11348647. DOI: 10.1186/s12888-024-06026-1.

Evaluation of viral suppression and medication-related burden among HIV-infected adults in a secondary care facility.

Hedima E, Ohieku J, David E, Ikunaiye N, Nasir A, Alfa M Explor Res Clin Soc Pharm. 2024; 15:100473.

PMID: 39108330 PMC: 11301334. DOI: 10.1016/j.rcsop.2024.100473.

Scoping review of measures of treatment burden in patients with multimorbidity: advancements and current gaps.

Mendoza-Quispe D, Perez-Leon S, Alarcon-Ruiz C, Gaspar A, Cuba-Fuentes M, Zunt J J Clin Epidemiol. 2023; 159:92-105.

PMID: 37217106 PMC: 10529536. DOI: 10.1016/j.jclinepi.2023.05.013.

Development and initial validation of the Chinese Version of the Noise Exposure Questionnaire (C-NEQ).

Han K, Wang Q, Yang L, Xu S, Li C, Lin J BMC Public Health. 2022; 22(1):207.

PMID: 35100992 PMC: 8805437. DOI: 10.1186/s12889-022-12648-5.

References

Mohammed M, Moles R, Chen T . Medication-related burden and patients' lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open. 2016; 6(2):e010035. PMC: 4746464. DOI: 10.1136/bmjopen-2015-010035. View

Jones P, Lee J, Phillips L, Zhang X, Jaceldo K . An adaptation of Brislin's translation model for cross-cultural research. Nurs Res. 2001; 50(5):300-4. DOI: 10.1097/00006199-200109000-00008. View

Katusiime B, Corlett S, Krska J . Development and validation of a revised instrument to measure burden of long-term medicines use: the Living with Medicines Questionnaire version 3. Patient Relat Outcome Meas. 2018; 9:155-168. PMC: 5978458. DOI: 10.2147/PROM.S151143. View

Krska J, Katusiime B, Corlett S . Patient experiences of the burden of using medicines for long-term conditions and factors affecting burden: A cross-sectional survey. Health Soc Care Community. 2018; 26(6):946-959. DOI: 10.1111/hsc.12624. View

Salive M . Multimorbidity in older adults. Epidemiol Rev. 2013; 35:75-83. DOI: 10.1093/epirev/mxs009. View

Tordoff J, Brenkley C, Krska J, Smith A . Exploring Medicines Burden Among Adults in New Zealand: A Cross-Sectional Survey. Patient Prefer Adherence. 2020; 13:2171-2184. PMC: 6930007. DOI: 10.2147/PPA.S231202. View

Sousa V, Rojjanasrirat W . Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2010; 17(2):268-74. DOI: 10.1111/j.1365-2753.2010.01434.x. View

Ozer Z, Firat M, Bektas H . Confirmatory and exploratory factor analysis of the caregiver quality of life index-cancer with Turkish samples. Qual Life Res. 2009; 18(7):913-21. DOI: 10.1007/s11136-009-9503-1. View

Zidan A, Awaisu A, Hasan S, Kheir N . The Living with Medicines Questionnaire: Translation and Cultural Adaptation into the Arabic Context. Value Health Reg Issues. 2016; 10:36-40. DOI: 10.1016/j.vhri.2016.07.001. View

10.

Krska J, Morecroft C, Poole H, Rowe P . Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013; 35(6):1161-9. DOI: 10.1007/s11096-013-9841-5. View

11.

Zhao Y, Atun R, Oldenburg B, McPake B, Tang S, Mercer S . Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. 2020; 8(6):e840-e849. PMC: 7241981. DOI: 10.1016/S2214-109X(20)30127-3. View

12.

Wang S, DArcy C, Yu Y, Li B, Liu Y, Tao Y . Prevalence and patterns of multimorbidity in northeastern China: a cross-sectional study. Public Health. 2015; 129(11):1539-46. DOI: 10.1016/j.puhe.2015.06.013. View

13.

Yang M, Lu J, Hao Q, Luo L, Dong B . Does residing in urban or rural areas affect the incidence of polypharmacy among older adults in western China?. Arch Gerontol Geriatr. 2014; 60(2):328-33. DOI: 10.1016/j.archger.2014.11.004. View

14.

Wei L, Champman S, Li X, Li X, Li S, Chen R . Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ Open. 2017; 7(10):e017293. PMC: 5640055. DOI: 10.1136/bmjopen-2017-017293. View

15.

Zidan A, Awaisu A, El-Hajj M, Al-Abdulla S, Figueroa D, Kheir N . Medication-Related Burden among Patients with Chronic Disease Conditions: Perspectives of Patients Attending Non-Communicable Disease Clinics in a Primary Healthcare Setting in Qatar. Pharmacy (Basel). 2018; 6(3). PMC: 6165107. DOI: 10.3390/pharmacy6030085. View

16.

Ulley J, Harrop D, Ali A, Alton S, Fowler Davis S . Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review. BMC Geriatr. 2019; 19(1):15. PMC: 6339421. DOI: 10.1186/s12877-019-1031-4. View

17.

Bentler P . Alpha, Dimension-Free, and Model-Based Internal Consistency Reliability. Psychometrika. 2010; 74(1):137-143. PMC: 2786226. DOI: 10.1007/s11336-008-9100-1. View

18.

van der Laan D, Elders P, Boons C, Nijpels G, Krska J, Hugtenburg J . The impact of cardiovascular medication use on patients' daily lives: a cross-sectional study. Int J Clin Pharm. 2018; 40(2):412-420. PMC: 5918518. DOI: 10.1007/s11096-018-0601-4. View

19.

Krska J, Morecroft C, Rowe P, Poole H . Measuring the impact of long-term medicines use from the patient perspective. Int J Clin Pharm. 2014; 36(4):675-8. DOI: 10.1007/s11096-014-9970-5. View

20.

. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet. 2018; 392(10152):1072-1088. DOI: 10.1016/S0140-6736(18)31992-5. View